About
I am a post doctoral cancer researcher in medical genomics group with a strong background in immunogenomics and bioinformatics. During my PhD, I established a cancer immunogenomics analysis pipeline to investigate tumour heterogeneity across different cancer types, focusing on both intrinsic and extrinsic mechanisms. My work has laid the foundation for developing computational methods to predict patient responses to immune checkpoint inhibitors.
My research focuses on characterizing genetic determinants that influence response and resistance to cancer immunotherapy. By leveraging whole genome and RNA sequencing, I identify tumour-specific neoantigens that can trigger T-cell responses. Through established immunogenomics analysis across various cancers, I explore tumor cell genomics and the immune landscape within the tumor microenvironment. My research aims to refine patient screening techniques, ensuring that individuals who would benefit most from immunotherapies receive the most effective treatment strategies.